At HKEX's 2026 Future Tech Summit, managing director and co-head of IPO review Liu Ying said 90 biotech companies have listed in Hong Kong under Chapter 18A since its 2018 introduction, raising HKD142.9 billion; 17 listed in 2025 and a further six in Jan–May 2026. She said Chapter 18C listings for specialised tech firms have accelerated — three in 2024, five in 2025 and ten in Jan–May 2026 — with the cohort concentrated in AI, robotics and autonomous-driving companies.

2026-06-11

At HKEX's 2026 Future Tech Summit, managing director and co-head of IPO review Liu Ying said 90 biotech companies have listed in Hong Kong under Chapter 18A since its 2018 introduction, raising HKD142.9 billion; 17 listed in 2025 and a further six in Jan–May 2026. She said Chapter 18C listings for specialised tech firms have accelerated — three in 2024, five in 2025 and ten in Jan–May 2026 — with the cohort concentrated in AI, robotics and autonomous-driving companies.